Filing Details
- Accession Number:
- 0001181431-10-036046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-02 13:00:00
- Reporting Period:
- 2010-07-01
- Filing Date:
- 2010-07-02
- Accepted Time:
- 2010-07-02 16:28:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401923 | Map Pharmaceuticals Inc. | MAPP | Pharmaceutical Preparations (2834) | 200507047 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1244229 | S Timothy Nelson | 2400 Bayshore Parkway, Suite 200 Mountain View CA 94043 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-07-01 | 15,000 | $0.64 | 38,963 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-07-01 | 15,000 | $12.15 | 23,963 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-07-01 | 15,000 | $0.00 | 15,000 | $0.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
232,549 | 2015-05-09 | No | 4 | M | Direct |
Footnotes
- The sale of the reported shares is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.
- The range of price is from $11.71 to $13.13 per share. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, or a security holder of the issuer.
- The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested.